<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02308189</url>
  </required_header>
  <id_info>
    <org_study_id>14F025</org_study_id>
    <secondary_id>1R21AR063909</secondary_id>
    <nct_id>NCT02308189</nct_id>
  </id_info>
  <brief_title>The Back Exercises to Neutralize Disability Study</brief_title>
  <acronym>BEND</acronym>
  <official_title>Novel Exercise Interventions to Improve Trunk Muscle Function: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Ohio University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A pilot randomized control trial (RCT) to generate effect sizes on the effects of blood flow&#xD;
      restricted exercise on trunk extensor cross-sectional area (primary outcome), strength and&#xD;
      endurance, whole body and regional lean mass and bone density, as well as the rate of&#xD;
      recurrence of LBP (secondary outcomes).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single-blinded, comparison-control group, single-center study of the effects of&#xD;
      exercise with and without blood flow restriction applied to the appendicular limbs on safety,&#xD;
      body composition (i.e., muscle mass), muscle strength, muscle endurance, whole body and&#xD;
      regional lean mass and bone density, and back pain and disability in male and female subjects&#xD;
      aged 18-50 years with recurrent low back pain and poor to moderate trunk extensor muscle&#xD;
      endurance.&#xD;
&#xD;
      Up to 50 subjects (2 arms) will be randomized in a 1:1 ratio to receive 10-weeks of&#xD;
      resistance exercise training with (group 1) or without blood flow restriction (group 2).&#xD;
      Randomization will be stratified by sex.&#xD;
&#xD;
      This study will have a screening period of 21 days (day -21 to day -1, screening and baseline&#xD;
      measures), a 10-week exercise treatment period (day 1 to day 70) and a 36-week follow up&#xD;
      period after the last exercise session (day 70 to day 322). The total duration of the study&#xD;
      from first exercise session will be approximately 46 weeks. Baseline measures for muscle size&#xD;
      (via MRI), muscle strength, muscle endurance, whole body and regional lean mass and bone&#xD;
      density (via DEXA), and measures of back pain and disability will be obtained between day -21&#xD;
      to -1.&#xD;
&#xD;
      Primary Endpoint: The primary endpoint is percent change in trunk extensor muscle&#xD;
      cross-sectional area measured by MRI at week 10 (study day 70) after start of exercise&#xD;
      training.&#xD;
&#xD;
      Secondary: The secondary endpoints include:&#xD;
&#xD;
        -  Muscle strength&#xD;
&#xD;
        -  Muscle endurance (time to task failure)&#xD;
&#xD;
        -  Whole body and regional lean mass by DEXA&#xD;
&#xD;
        -  Whole body and regional bone density by DEXA&#xD;
&#xD;
        -  Pain&#xD;
&#xD;
        -  Disability&#xD;
&#xD;
        -  Safety&#xD;
&#xD;
        -  Treatment acceptability Procedures and Assessments Efficacy measures (MRI, muscle&#xD;
           strength, muscle endurance, lean mass, bone density, pain, and disability) will be&#xD;
           obtained at screening and at week 10 (day 70) and week 20 (day 154).&#xD;
&#xD;
      Safety of blood flow restricted exercise will be assessed based on adverse event findings and&#xD;
      monitoring. Subjects will be asked to monitor and report all adverse events (AEs) experienced&#xD;
      from the time the informed consent is signed until the end-of-study visit.&#xD;
&#xD;
      Treatment acceptability will be determined by administering the Treatment Evaluation&#xD;
      Inventory survey at the end of the fourth and sixteenth exercise sessions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">May 24, 2017</completion_date>
  <primary_completion_date type="Actual">November 24, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Trunk Extensor Muscle Cross Sectional Area % of Change</measure>
    <time_frame>Baseline and following 10-weeks of exercise training. Values are calculated from % change.</time_frame>
    <description>The primary endpoint is percent change in trunk extensor muscle cross-sectional area measured by The primary endpoint is percent change in trunk extensor muscle cross-sectional area measured by MRI at week 10 (study day 70) after start of exercise training.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle Strength % of Change</measure>
    <time_frame>Baseline and following 10-weeks of exercise training. Values calculated are % of change</time_frame>
    <description>Maximal muscle strength</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Endurance (Time to Task Failure) % of Change</measure>
    <time_frame>Baseline and following 10-weeks of exercise training. Values are calculated on % of change.</time_frame>
    <description>Time for successfully performing a sustained, submaximal muscle contraction</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low load resistance exercise training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise with blood flow restriction</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low load resistance exercise training with blood flow restriction</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise with blood flow restriction</intervention_name>
    <description>Low load resistance exercise performed with an external pressure cuff applied over both legs or both arms during respective leg and arm exercises.</description>
    <arm_group_label>Exercise with blood flow restriction</arm_group_label>
    <other_name>Kaatsu Training with Blood Flow Restricted Exercise</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Low load resistance exercise performed with no external pressure cuff applied to the appendicular limbs.</description>
    <arm_group_label>Exercise</arm_group_label>
    <other_name>Resistance exercise</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Men and women aged 18 to 50 years, with no significant health issues or conditions&#xD;
             that, in the investigator's opinion, would limit the subject's ability to complete the&#xD;
             study per protocol or that would impact the capability to get an accurate measurement&#xD;
             of study endpoints.&#xD;
&#xD;
          2. Answer yes to the following question: Have you had two or more episodes of low back&#xD;
             pain in the past 12-months with at least one of the episodes causing a restriction of&#xD;
             work or leisure time activity?&#xD;
&#xD;
          3. Exhibit low trunk extensor endurance defined as the time to task failure during the&#xD;
             modified-Sorenson test of less than 176 seconds.&#xD;
&#xD;
          4. Body mass index (BMI) between 19 and 37 kg/m2 inclusive.&#xD;
&#xD;
          5. With no condition that could limit participation in supervised resistance training&#xD;
             exercise based on the Physical Activity Readiness Questionnaire (PAR-Q) (i.e., if a&#xD;
             study participant answers yes to questions 1-4 they will be excluded, if they answer&#xD;
             yes to 5-7 they will require clearance for participation by the study physician).&#xD;
&#xD;
          6. Sedentary lifestyle defined by a classification of &quot;low&quot; or &quot;moderate&quot; levels of&#xD;
             physical activity based on the scoring criteria for the International Physical&#xD;
             Activity Questionnaire (IPAQ).&#xD;
&#xD;
          7. Willing to maintain current diet and adhere to exercise programs described for the&#xD;
             study and to not start any new dieting/weight management programs.&#xD;
&#xD;
          8. Willing and able to return for all clinic visits and complete all study-related&#xD;
             procedures.&#xD;
&#xD;
          9. Able to read, understand, and complete study-related questionnaires&#xD;
&#xD;
         10. Able to read and understand, and willing to sign the informed consent form (ICF).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Participation in progressive resistance exercise within the previous 24 weeks prior to&#xD;
             screening.&#xD;
&#xD;
          2. Participation in any clinical trial within 24 weeks prior to screening.&#xD;
&#xD;
          3. Hospitalization (medical confinement for ≥24 hours), or immobilization, or major&#xD;
             surgical procedure requiring general anesthesia within 24 weeks prior to screening, or&#xD;
             any planned surgical procedures during the study period.&#xD;
&#xD;
          4. Limb amputation (except for toes) and/or any fracture within 24 weeks.&#xD;
&#xD;
          5. Osteoarthritis, rheumatologic diseases or orthopedic disorders which will not allow&#xD;
             completion of the motions required for the resistance exercise.&#xD;
&#xD;
          6. Conditions (such as myasthenia gravis, myositis, muscular dystrophy or myopathy,&#xD;
             including drug-induced myopathy) leading to muscle loss, muscle weakness, muscle&#xD;
             cramps or myalgia.&#xD;
&#xD;
          7. Chronic or relapsing/remitting gastrointestinal disorders such as inflammatory bowel&#xD;
             diseases, irritable bowel syndrome or gastrointestinal infections within 28 days of&#xD;
             screening.&#xD;
&#xD;
          8. Acute viral or bacterial upper or lower respiratory infection at screening&#xD;
&#xD;
          9. Moderate or severe chronic obstructive pulmonary disease.&#xD;
&#xD;
         10. Back pain greater than 4 (on a 10 point numeric pain rating scale) at screening&#xD;
&#xD;
         11. Leg length discrepancy &gt; 3 cm.&#xD;
&#xD;
         12. Current or recent (i.e., within 12 weeks) of narcotics or muscle relaxants.&#xD;
&#xD;
         13. Currently pregnant (confirmed via a urine test) or planning to become pregnant within&#xD;
             the next year at screening.&#xD;
&#xD;
         14. Report unexplained weight loss over the past 30 days (&gt; 10 pounds).&#xD;
&#xD;
         15. Report having pending litigation related to low back pain or currently receiving&#xD;
             disability for low back pain.&#xD;
&#xD;
         16. Report having received treatment for low back pain from a health care practitioner in&#xD;
             the past 6 weeks.&#xD;
&#xD;
         17. History of spine surgery or hip arthroplasty.&#xD;
&#xD;
         18. Cancer requiring treatment currently or in the past 3 years (except primary&#xD;
             non-melanoma skin cancer or in situ cervical cancer)&#xD;
&#xD;
         19. Moderate or severe asthma with current or recurring symptoms within the last 1-year.&#xD;
&#xD;
         20. Known history of human immunodeficiency virus (HIV) antibody and/or positive hepatitis&#xD;
             B surface antigen (HBsAg) and/or positive hepatitis C antibody (HCV) at screening.&#xD;
&#xD;
         21. Neurological conditions resulting in impaired muscle function or mobility (e.g.,&#xD;
             stroke with residual paresis, paralysis, multiple sclerosis, or Parkinson Disease).&#xD;
&#xD;
         22. Psychiatric conditions that warrant acute or chronic therapeutic intervention (e.g.,&#xD;
             major depressive disorder, bipolar disorder, panic disorder, schizophrenia) that in&#xD;
             the investigators opinion may interfere with the conduct of study procedures&#xD;
&#xD;
         23. History of cardiac conditions such as heart failure (NYHA class II-IV), angina&#xD;
             (including unstable angina), myocardial infarction, cardiomyopathy, any cardiac&#xD;
             arrhythmia (except stable sinus dysrhythmia or atrial fibrillation) or valvular heart&#xD;
             disease (except asymptomatic mitral valve prolapse).&#xD;
&#xD;
         24. History of peripheral vascular disease.&#xD;
&#xD;
         25. Subjects with the following abnormal ECG findings at screening will be excluded:&#xD;
&#xD;
             Electrocardiogram findings indicative of left ventricular hypertrophy (LVH) (based on&#xD;
             Cornell voltage criteria): For men: S in V3 plus R in a VL &gt;2.8 mV (28 mm) For women:&#xD;
             S in V3 plus R in a VL &gt;2.0 mV (20 mm) Electrocardiogram finding of QT prolongation&#xD;
             defined as QTcF &gt; 470 ms&#xD;
&#xD;
         26. Diabetics using insulin are excluded.&#xD;
&#xD;
         27. Abnormal or uncontrolled blood pressure at the screening visit defined as diastolic BP&#xD;
             &gt;100 and/or systolic BP &gt;160 mm Hg; if taking anti-hypertensive medication, have to be&#xD;
             on stable doses of medication for more than 3 months.&#xD;
&#xD;
         28. Current or recent history (within 1 year of screen) of heavy alcohol consumption&#xD;
             (males ≥ 21 drinks/week, 4 drinks/day; females ≥ 14 drinks/week, 3 drinks/day) or drug&#xD;
             abuse.&#xD;
&#xD;
         29. Current or previous use of any drugs known to influence muscle mass or performance&#xD;
             within 24 weeks. These may include, but are not limited to, anabolic steroids, IGF-1,&#xD;
             growth hormone (GH), replacement androgen therapy, anti-androgen therapy.&#xD;
&#xD;
         30. Use of systemic glucocorticoids within 12 weeks prior to screening.&#xD;
&#xD;
         31. Having body dimensions that exceed the MRI or exercise equipment limits.&#xD;
&#xD;
         32. Unable to undergo MRI (e. g. body containing any metallic medical devices or&#xD;
             equipment, including heart pacemakers, metal prostheses, implants or surgical clips,&#xD;
             any prior injury from shrapnel or grinding metal, exposure to metallic dusts, metallic&#xD;
             shavings or having tattoos containing metallic dyes).&#xD;
&#xD;
         33. Unable to reliably undergo exercise or strength tests described for this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brian C Clark, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio Musculoskeletal and Neurological Institute (OMNI)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ohio Musculoskeletal and Neurological Institute (OMNI) at Ohio University</name>
      <address>
        <city>Athens</city>
        <state>Ohio</state>
        <zip>45701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>December 2, 2014</study_first_submitted>
  <study_first_submitted_qc>December 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2014</study_first_posted>
  <results_first_submitted>April 3, 2018</results_first_submitted>
  <results_first_submitted_qc>May 18, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">June 19, 2018</results_first_posted>
  <last_update_submitted>May 18, 2018</last_update_submitted>
  <last_update_submitted_qc>May 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exercise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Exercise</title>
          <description>Low load resistance exercise training&#xD;
Exercise: Low load resistance exercise performed with no external pressure cuff applied to the appendicular limbs.</description>
        </group>
        <group group_id="P2">
          <title>Exercise With Blood Flow Restriction</title>
          <description>Low load resistance exercise training with blood flow restriction&#xD;
Exercise with blood flow restriction: Low load resistance exercise performed with an external pressure cuff applied over both legs or both arms during respective leg and arm exercises.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>a total of 32 participants were randomized, 2 were withdrawn after randomization</population>
      <group_list>
        <group group_id="B1">
          <title>Exercise</title>
          <description>Low load resistance exercise training&#xD;
Exercise: Low load resistance exercise performed with no external pressure cuff applied to the appendicular limbs.</description>
        </group>
        <group group_id="B2">
          <title>Exercise With Blood Flow Restriction</title>
          <description>Low load resistance exercise training with blood flow restriction&#xD;
Exercise with blood flow restriction: Low load resistance exercise performed with an external pressure cuff applied over both legs or both arms during respective leg and arm exercises.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Two subjects withdrew after randomization. Analysis completed on 30 subjects</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="16"/>
                    <count group_id="B2" value="14"/>
                    <count group_id="B3" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="15"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.9" spread="10.3"/>
                    <measurement group_id="B2" value="28.4" spread="9.2"/>
                    <measurement group_id="B3" value="29.2" spread="9.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="15"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="15"/>
                    <count group_id="B3" value="32"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Trunk Extensor Muscle Cross Sectional Area % of Change</title>
        <description>The primary endpoint is percent change in trunk extensor muscle cross-sectional area measured by The primary endpoint is percent change in trunk extensor muscle cross-sectional area measured by MRI at week 10 (study day 70) after start of exercise training.</description>
        <time_frame>Baseline and following 10-weeks of exercise training. Values are calculated from % change.</time_frame>
        <population>Per protocol analysis of completed study participants</population>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Low load resistance exercise training&#xD;
Exercise: Low load resistance exercise performed with no external pressure cuff applied to the appendicular limbs.</description>
          </group>
          <group group_id="O2">
            <title>Exercise With Blood Flow Restriction</title>
            <description>Low load resistance exercise training with blood flow restriction&#xD;
Exercise with blood flow restriction: Low load resistance exercise performed with an external pressure cuff applied over both legs or both arms during respective leg and arm exercises.</description>
          </group>
        </group_list>
        <measure>
          <title>Trunk Extensor Muscle Cross Sectional Area % of Change</title>
          <description>The primary endpoint is percent change in trunk extensor muscle cross-sectional area measured by The primary endpoint is percent change in trunk extensor muscle cross-sectional area measured by MRI at week 10 (study day 70) after start of exercise training.</description>
          <population>Per protocol analysis of completed study participants</population>
          <units>percentage of change</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.7" spread="1.0"/>
                    <measurement group_id="O2" value="-3.9" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Muscle Strength % of Change</title>
        <description>Maximal muscle strength</description>
        <time_frame>Baseline and following 10-weeks of exercise training. Values calculated are % of change</time_frame>
        <population>Study participants completing study.</population>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Low load resistance exercise training&#xD;
Exercise: Low load resistance exercise performed with no external pressure cuff applied to the appendicular limbs.</description>
          </group>
          <group group_id="O2">
            <title>Exercise With Blood Flow Restriction</title>
            <description>Low load resistance exercise training with blood flow restriction&#xD;
Exercise with blood flow restriction: Low load resistance exercise performed with an external pressure cuff applied over both legs or both arms during respective leg and arm exercises.</description>
          </group>
        </group_list>
        <measure>
          <title>Muscle Strength % of Change</title>
          <description>Maximal muscle strength</description>
          <population>Study participants completing study.</population>
          <units>percentage of change from baseline</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.4" spread="3.1"/>
                    <measurement group_id="O2" value="4.7" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Muscle Endurance (Time to Task Failure) % of Change</title>
        <description>Time for successfully performing a sustained, submaximal muscle contraction</description>
        <time_frame>Baseline and following 10-weeks of exercise training. Values are calculated on % of change.</time_frame>
        <population>Study participants completing study.</population>
        <group_list>
          <group group_id="O1">
            <title>Exercise</title>
            <description>Low load resistance exercise training&#xD;
Exercise: Low load resistance exercise performed with no external pressure cuff applied to the appendicular limbs.</description>
          </group>
          <group group_id="O2">
            <title>Exercise With Blood Flow Restriction</title>
            <description>Low load resistance exercise training with blood flow restriction&#xD;
Exercise with blood flow restriction: Low load resistance exercise performed with an external pressure cuff applied over both legs or both arms during respective leg and arm exercises.</description>
          </group>
        </group_list>
        <measure>
          <title>Muscle Endurance (Time to Task Failure) % of Change</title>
          <description>Time for successfully performing a sustained, submaximal muscle contraction</description>
          <population>Study participants completing study.</population>
          <units>percentage of change from baseline</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="25.1" spread="4.9"/>
                    <measurement group_id="O2" value="21.0" spread="5.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events were monitored and assessed for each subject for 9-months</time_frame>
      <desc>AE definitions followed clinicaltrials.gov definitions.</desc>
      <group_list>
        <group group_id="E1">
          <title>Exercise</title>
          <description>Low load resistance exercise training&#xD;
Exercise: Low load resistance exercise performed with no external pressure cuff applied to the appendicular limbs.</description>
        </group>
        <group group_id="E2">
          <title>Exercise With Blood Flow Restriction</title>
          <description>Low load resistance exercise training with blood flow restriction&#xD;
Exercise with blood flow restriction: Low load resistance exercise performed with an external pressure cuff applied over both legs or both arms during respective leg and arm exercises.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Brian Clark, PhD</name_or_title>
      <organization>Ohio University</organization>
      <phone>740-593-2354</phone>
      <email>clarkb2@ohio.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

